Nnenna Nelson
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. 2024 is the largest year on record at $2,239, more than ten times the $86 reported in 2021. Among family clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 167 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$479
- AbbVie$333
- AstraZeneca$276
- Aurinia Pharma U.S., Inc.$273
- Amgen$249
- Paratek Pharmaceuticals, Inc.$245
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,41595%
- Education$1755%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $479 |
| AbbVie | 18 | $333 |
| AstraZeneca(2 entities) | 12 | $276 |
| Aurinia Pharma U.S., Inc. | 15 | $273 |
| Amgen | 11 | $249 |
| Paratek Pharmaceuticals, Inc. | 14 | $245 |
| ANI Pharmaceuticals, Inc. | 10 | $225 |
| Novartis | 8 | $222 |
| Pfizer | 13 | $215 |
| Lilly USA, LLC | 9 | $208 |
| Fresenius Kabi USA, LLC | 5 | $100 |
| Tersera Therapeutics LLC | 4 | $98 |
| Boehringer Ingelheim | 4 | $81 |
| Mallinckrodt Hospital Products Inc. | 3 | $76 |
| Actelion Pharmaceuticals US, Inc. | 3 | $71 |
| UCB, Inc. | 3 | $68 |
| Sandoz | 3 | $58 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $47 |
| Hartmann USA, Inc. | 2 | $47 |
| Radius Health, Inc. | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| Convatec Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Genentech USA, Inc. | 1 | $13 |
| Cashflow Solutions, LLC | 1 | $13 |
How this compares
$3,590 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Other family in Katy
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.